Dr. Attila Bérces Received the Icarus Innovation Award

14/11/2018

We are very proud and happy to announce that Attila Bérces, Founder and Chairman of Omixon received the Icarus Innovation Award by the Chamber of Commerce and Industry for Győr-Moson-Sopron County, Hungary. Congratulations! Read the article in Hungarian here…

Crabs, Epitopes and Revolutionary Products – the Highlights of ASHI 2018

25/10/2018

Thank you everyone for visiting us and joining our events during the 44th Annual ASHI Meeting. The Omixon Team – Efi, Maggi, Ellia, Renata, Nora, Kriszta, Pete, Dan, Gergo and Attila – went on a trip to Baltimore, Maryland, the home of crab cakes, a stunning harbor and lots...

It Is Not You Who Chooses Your Partner… But Your HLA Genes!

24/10/2018

Written by Nina Lauterbach, PhD (Field Application Scientist, Omixon) Animals, and us humans, are daily under attack by viruses and other pathogens. Fortunately, we are equipped with the Major Histocompatibility Complex (MHC) as an efficient and adaptable fighting mechanism to deal with these threatening events. This complex is encoded...

Automated NGS-based HLA Typing and Epitope Matching at the 44th ASHI Annual Meeting 2018

27/09/2018

Omixon announce today that Holotype HLA and other Omixon products will be featured among nine posters produced by customers or collaborators at the annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s Lunch Symposium on Thursday 10/4 will focus on the importance...

Omixon & PIRCHE® collaborate on Epitope Determination with NGS

17/09/2018

Global molecular diagnostics company Omixon, headquartered in Budapest, and technology company PIRCHE AG, headquartered in Berlin announce a collaboration to deliver the first integrated epitope determination and matching service that leverages whole gene consensus sequences assembled from NGS data of the HLA region. For the first time, fully characterized...